Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus | Zendy

Eduardo Lujan | Zendy; Kathleen Winter | Zendy; Jillandra Rovaris | Zendy; Qin Liu | Zendy; Dan M. Granoff | Zendy

Open Access

Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus

Author(s) -

Eduardo Lujan,

Kathleen Winter,

Jillandra Rovaris,

Qin Liu,

Dan M. Granoff

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix519

Subject(s) - medicine , outbreak , meningococcal disease , titer , meningococcal vaccine , confidence interval , antibody titer , virology , antibody , immunology , neisseria meningitidis , immunization , biology , bacteria , genetics

MenB-4C is a recently licensed meningococcal serogroup B vaccine. For vaccine licensure, short-term efficacy was inferred from serum bactericidal antibody (SBA) titers against 3 antigen-specific indicator strains, which are not necessarily representative of US disease-causing strains.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research